Celox (chitosan) for haemostasis in massive traumatic bleeding: experience in Afghanistan

Eur J Emerg Med. 2011 Feb;18(1):31-3. doi: 10.1097/MEJ.0b013e32833a5ee4.

Abstract

The use of Celox, a chitosan-based haemostatic agent, for the control of massive traumatic bleeding in patients arriving at a ROLE 2 (Enhanced Care) Facility in southwestern Afghanistan is described. Twenty-one soldiers with gunshot wounds were treated with successful haemostasis in 18 at the first application and in three after further applications. Celox is an effective haemostatic agent and a useful adjunct for the treatment of massive traumatic bleeding.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Afghan Campaign 2001-
  • Afghanistan
  • Biocompatible Materials / administration & dosage*
  • Blood Loss, Surgical / prevention & control*
  • Chitosan / administration & dosage*
  • Hemostasis / drug effects
  • Humans
  • Male
  • Postoperative Hemorrhage / prevention & control*
  • Wounds, Gunshot / drug therapy*
  • Young Adult

Substances

  • Biocompatible Materials
  • Chitosan